Gut Health Peptides: GI Research & Healing Compounds
Peptides studied for gastrointestinal healing include BPC-157, which has extensive preclinical evidence in animal models for GI tract protection, ulcer healing, and inflammatory bowel conditions.
BPC-157 (Body Protection Compound 157) originates from gastric juice proteins and has been investigated in dozens of animal studies for ulcer healing, IBD, leaky gut, and esophageal damage. The preclinical literature is unusually large for a research peptide. However, human clinical trial data remains minimal — mostly case reports and one small open-label trial. FDA placed BPC-157 on the 503A Do Not Compound list in 2023, eliminating the compounding pathway. Patients with serious GI conditions should work with gastroenterologists on standard-of-care treatment; BPC-157 is not a substitute for evidence-based therapy for conditions like IBD, celiac disease, or GERD. The preclinical evidence is strong enough to warrant human trials, but not strong enough to recommend BPC-157 for GI conditions outside of research settings.
1 compound in this category
Key Takeaways
- BPC-157 has the largest preclinical GI evidence base of any research peptide
- Human clinical trial data is minimal — mostly case reports
- FDA placed BPC-157 on the 503A Do Not Compound list in 2023
- It is not a substitute for evidence-based treatment of IBD, celiac disease, or GERD
- Research chemical sources carry significant purity and contamination risk
Compounds in This Category
Frequently Asked Questions
Does BPC-157 help IBD or Crohn's?
Preclinical evidence suggests benefit in animal IBD models, but no controlled human trials exist. It should not replace standard IBD therapy.
Is BPC-157 legal for human use?
No. Following the 2023 FDA 503A ruling, it is neither FDA-approved nor legally compoundable in the US.
Can BPC-157 heal "leaky gut"?
"Leaky gut syndrome" is not a recognized medical diagnosis. Preclinical BPC-157 studies show intestinal barrier effects in animals; translation to human conditions is speculative.
How long does BPC-157 take to work for GI issues?
Animal studies show measurable effects within 2–4 weeks. Human reports are variable and uncontrolled.
What are safer alternatives?
For most GI conditions, evidence-based treatments (PPIs for GERD, biologics for IBD, dietary management) have far stronger support than any research peptide.